Align Technology Inc. ($ALGN) Stock Forecast: Down 7.1% Today

What is Align Technology Inc.?

Align Technology Inc. (ALGN) is a global medical device company that designs, manufactures, and sells the Invisalign clear aligner system for teeth straightening. The company is known for its innovative orthodontic solutions and cutting-edge technology in the dental industry.

Why is Align Technology Inc. going down?

ALGN stock is down 7.1% on Mar 27, 2026 17:06

• The bearish movement in ALGN stock today could be attributed to the significant reduction in stake by Riverbridge Partners LLC, selling 119,935 shares in Q4, which might have raised concerns among investors about the company's growth prospects.
• Additionally, the removal of ALGN from the FTSE All-World Index could have impacted passive investment flows and liquidity, leading to selling pressure on the stock as large institutional investors adjust their exposure to the company.
• The realignment of Vanguard's holdings, with ALGN now showing 0% ownership, might have added to the negative sentiment around the stock as investors react to changes in major institutional positions.
• Despite ALGN recently surpassing analyst expectations for earnings and revenue, these external factors such as stake sell-offs and index removal could have overshadowed the positive performance, contributing to the bearish market movement today.

ALGN Price Chart

ALGN Technical Analysis

ALGN News

Reasons to Add Cooper Companies Stock to Your Portfolio Now

The Cooper Companies (COO) is recommended as a Zacks Rank #2 (Buy) stock due to its market share gains, premium product momentum in CooperVision, and strong margin expansion driven by operational efficiencies and AI adoption. CooperSurgical's growth is also supported by recovery trends in the fertility market. Despite challenges like Asia-Pacific weakness and geopolitical risks, the company's long-term opportunities are strong.

https://www.theglobeandmail.com/investing/markets/stocks/CAH/pressreleases/1006383/reasons-to-add-cooper-companies-stock-to-your-portfolio-now/

Reasons to Add Cooper Companies Stock to Your Portfolio Now

The Cooper Companies (COO) is positioned for growth due to the success of its CooperVision premium lens migration and MiSight's myopia management, alongside CooperSurgical's women's health portfolio. While facing near-term challenges like Asia-Pacific weakness and geopolitical risks affecting its fertility segment, the company shows strong long-term potential fueled by market share gains, operational efficiencies, and recovery in the fertility market. Analysts project a 5.5% revenue growth and 11.7% adjusted EPS improvement for fiscal 2026.

https://www.tradingview.com/news/zacks:35cc6942b094b:0-reasons-to-add-cooper-companies-stock-to-your-portfolio-now/

Riverbridge Partners LLC Sells 119,935 Shares of Align Technology, Inc. $ALGN

Riverbridge Partners LLC significantly reduced its stake in Align Technology (NASDAQ:ALGN) by selling 119,935 shares in Q4, now holding 0.10% of the company valued at $11.45 million. Concurrently, an EVP also sold a substantial portion of his shares. Despite this, Align Technology recently surpassed analyst expectations for earnings and revenue, maintaining a "Moderate Buy" analyst rating.

https://www.marketbeat.com/instant-alerts/filing-riverbridge-partners-llc-sells-119935-shares-of-align-technology-inc-algn-2026-03-27/

The Bull Case For Align Technology (ALGN) Could Change Following FTSE All-World Index Removal – Learn Why

Align Technology (ALGN) was recently removed from the FTSE All-World Index, which could impact its passive investment flows and liquidity profile by affecting how large institutional investors gain exposure to the company. While the exclusion doesn't alter Align's near-term drivers like case volumes and pricing pressures, it introduces a technical factor that intersects with these challenges. Investors should consider how this index change might influence the company's longer-term narrative, especially in light of its revenue guidance and pressure on profitability.

https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/the-bull-case-for-align-technology-algn-could-change-followi-3

Vanguard disaggregates holdings; ALGN shows 0% ownership after realignment

The Vanguard Group filed an amended Schedule 13G for Align Technology Inc (ALGN), reporting 0% beneficial ownership following an internal realignment on January 12, 2026. This realignment means certain Vanguard subsidiaries will now report their ownership separately, based on SEC Release No. 34-39538. The filing explicitly states Vanguard itself holds no voting or dispositive power over ALGN shares as of March 13, 2026.

https://www.stocktitan.net/sec-filings/ALGN/schedule-13g-a-align-technology-inc-amended-passive-investment-disclo-87e2d1e9898f.html

Trending Today

Groupon Inc. ($GRPN) Stock Forecast: Down 5.2% Today

Amplitude Inc. ($AMPL) Stock Forecast: Down 5.2% Today

Ambarella Inc. ($AMBA) Stock Forecast: Down 5.7% Today

PTC Inc. ($PTC) Stock Forecast: Down 5.3% Today

LyondellBasell Industries NV Class A (Netherlands) ($LYB) Stock Forecast: Up 5.3% Today

Teleflex Incorporated ($TFX) Stock Forecast: Up 5.1% Today

Southwest Airlines Company ($LUV) Stock Forecast: Down 5.3% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Down 6.7% Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 12.6% Today

Alaska Air Group Inc. ($ALK) Stock Forecast: Down 5.5% Today

Align Technology Inc. Price History

27.02.2026 - ALGN Stock was down 7.4%

• ALGN was removed from the FTSE All-World Index, impacting passive investment flows and liquidity, potentially affecting institutional investor exposure.
• A realignment by Vanguard resulted in 0% ownership of ALGN shares, signaling a change in their investment strategy.
• The stock underperformed compared to competitors in a market downturn, trading below its 52-week high achieved in July.
• Reports of Elliott Investment Management taking a large position in ALGN led to a jump in shares, indicating potential changes or shareholder activism that could have influenced the market movement.

06.01.2026 - ALGN Stock was up 5.1%

• A higher price target of $220 set by Piper Sandler for Align Technology post a robust Q4 showing, with revenue reaching $1.048 billion and $3.29 EPS, has bolstered investor confidence, resulting in a positive trend in the stock.
• Record revenue achieved by the company in Q4 and fiscal 2025, attributed to a significant increase in Clear Aligner case volumes worldwide, signals its strong market position and growth prospects, further elevating investor optimism.
• Despite negative earnings forecasts, Align Technology's strong performance and favorable 2026 outlook demonstrate its adept navigation of challenges and effective capitalization on market opportunities, contributing to the upward momentum in the market.

13.01.2026 - ALGN Stock was down 5.9%

• The bearish movement in ALGN stock today might be linked to profit-taking by institutional investors like Candriam S.C.A. and Savant Capital LLC, who have recently decreased their holdings in the company.
• Despite exceeding quarterly earnings and revenue expectations, market sentiments could be influenced by analysts' concerns regarding potential margin dilution from new technologies, surfaced during the Q4 earnings call.
• Ongoing legal disputes with Angelalign Technology Inc. concerning patent infringement and the uncertainty surrounding a preliminary European court ruling on software features could be exerting downward pressure on the stock.
• While the collaboration with the University of Bern for the Oral Health Study signals a promising avenue for market enlargement, investors could be exercising caution due to uncertainties about immediate sales impact and potential pricing challenges in public health programs.

27.02.2026 - ALGN Stock was down 7.1%

• The bearish movement in ALGN stock today could be attributed to the significant reduction in stake by Riverbridge Partners LLC, selling 119,935 shares in Q4, which might have raised concerns among investors about the company's growth prospects.
• Additionally, the removal of ALGN from the FTSE All-World Index could have impacted passive investment flows and liquidity, leading to selling pressure on the stock as large institutional investors adjust their exposure to the company.
• The realignment of Vanguard's holdings, with ALGN now showing 0% ownership, might have added to the negative sentiment around the stock as investors react to changes in major institutional positions.
• Despite ALGN recently surpassing analyst expectations for earnings and revenue, these external factors such as stake sell-offs and index removal could have overshadowed the positive performance, contributing to the bearish market movement today.

24.01.2026 - ALGN Stock was up 5.2%

• ALGN stock saw a significant bullish movement recently.
• The company's strategic focus on digital workflows, international expansion, and targeting large dental networks appears to have excited investors.
• The integration of Align Technology's iTero intraoral scanners with Henry Schein One's Dentrix practice management platforms is viewed positively for streamlining digital workflows in dental practices, potentially boosting long-term profitability.
• Align Technology's attention to children's early dental habits demonstrates its dedication to promoting oral health, which could enhance its brand reputation and customer loyalty.

10.02.2026 - ALGN Stock was up 5.0%

• Fieldview Capital Management LLC and Rhenman & Partners Asset Management AB acquiring additional shares of ALGN indicate confidence in the company's future prospects, contributing to the bullish movement.
• The robust growth of the Invisible Orthodontic Appliance Market, in which Align Technology is a key player, is driving investor optimism and interest in the stock.
• Despite recent share price pullbacks, ALGN's strong earnings performance, expanding clinical indications for Invisalign, and expected double-digit earnings growth are factors supporting the bullish trend.
• The company's higher-than-industry-average P/E ratio and potential valuation risk if market sentiment shifts highlight the need for investors to monitor market dynamics closely despite the current positive momentum.

03.11.2025 - ALGN Stock was up 5.1%

• ALGN experienced a strong bullish movement today, driven by several positive developments:
• The launch of new aligner options and direct fabrication technology is expected to drive growth and margin gains for the company.
• Expansion into new markets like South Africa and the Philippines with innovative digital dentistry solutions is enhancing ALGN's global presence.
• The company's focus on digital innovation, patient engagement, and personalized treatment journeys is resonating well with practitioners and patients alike.
• Despite a recent share price jump and positive news flow, there is still a debate about the stock's valuation, with some suggesting it may be undervalued due to expanding clinical indications and increased adoption by dentists.

12.01.2026 - ALGN Stock was down 5.1%

• ALGN surpassed earnings and revenue projections for the quarter but faced a downward trend in the market.
• Reductions in ownership stakes by institutional investors like Candriam S.C.A. and Savant Capital LLC may have influenced the negative market sentiment towards ALGN.
• Analysts' scrutiny of average selling prices and potential profit dilution from new technologies during the earnings briefing likely sparked concerns among investors, impacting the stock's performance.
• Despite the current market pessimism, the optimistic forecast for growth in the global dental impression systems market, attributed to technological progress and rising demand, could signify a favorable long-term outlook for ALGN.

05.01.2026 - ALGN Stock was up 10.2%

• The company reported better-than-expected Q4 2025 earnings and revenue, with record revenues and clear aligner volumes, leading to a significant surge in its stock price.
• Despite the company's gross and operating margins contracting due to increased costs and expenses, investors were still impressed by the overall performance and outlook for 2026 revenue growth.
• The positive outlook for the company, driven by strategic priorities like international expansion and increased orthodontic utilization, contributed to the bullish sentiment surrounding ALGN stock.
• The market's enthusiastic response to the earnings report and optimistic projections reflects investors' confidence in the company's growth potential and ability to navigate the dynamic macro environment.

03.01.2026 - ALGN Stock was down 5.2%

• The stock of Align Technology (ALGN) recently saw a significant decrease, potentially influenced by various factors:
• Historical patterns of missing revenue estimates in previous quarters may have caused investor uncertainty and selling pressure, despite the current expectations of revenue growth and earnings per share.
• A partnership with the University of Bern for a notable epidemiological study on oral health trends in Switzerland, though enhancing the company's reputation, may not have yielded immediate benefits to bolster investor confidence.
• Efforts to support healthcare research and initiatives, although laudable, might not have directly translated into immediate financial gains, contributing to a negative investor outlook.
• General market conditions and sector-specific influences could have also affected ALGN stock's decline, as overall market trends can impact individual stock performance.

17.02.2026 - ALGN Stock was up 6.0%

• Analysts have upgraded Align Technology from Equal-Weight to Overweight, setting a price target of $200. This upgrade signifies a higher level of confidence in the company's market standing and its potential for future success.
• Despite concerns about sluggish organic revenue growth and difficulties in the Asia Pacific region, Align Technology has shown strong performance, including impressive Q4 results and outperforming the Nasdaq. These factors have contributed to its positive market movement.
• By organizing the Southeast Asia Forum to address dental innovation and trends, Align Technology is demonstrating its dedication to advancing dental health and strengthening its presence in the region. This initiative has bolstered investor optimism about the company's growth prospects.
• The underperformance of Cooper Companies (COO) in comparison to Align Technology and the overall market might have prompted investors to shift their focus towards Align Technology, thereby fueling its positive market trend.

17.02.2026 - ALGN Stock was up 6.3%

• The recent Southeast Asia Forum showcased (ALGN)'s dedication to dental innovation and collaboration with medical experts, boosting investor confidence in its leadership in the dental technology sector.
• The positive market outlook for digital dentistry, with its rapid expansion and potential, may have influenced the bullish movement in (ALGN)'s stock. Investors seem optimistic about the company's growth in this thriving sector.
• While some dental companies face performance challenges, (ALGN)'s strategic focus on advancing dental health through initiatives like the Southeast Asia Forum has positioned it well in the market. This commitment to innovation likely contributed to today's bullish performance.